This inventor holds 1 USPTO granted patent. Top assignee: Green Cross Holdings Corporation. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Jong Kyung Kim: Innovator in Hepatitis B Immunoglobulin Preparation
Introduction
Jong Kyung Kim is a notable inventor based in Cheongju, South Korea. He has made significant contributions to the field of immunology, particularly in the preparation of hepatitis B immunoglobulin derived from human plasma. His innovative methods have the potential to enhance the quality and efficiency of immunoglobulin production.
Latest Patents
Jong Kyung Kim holds a patent for "Methods for preparing hepatitis B immunoglobulin derived from plasma." This invention focuses on a preparation method that involves dialysis concentration of plasma protein fraction II, which contains human hepatitis B immunoglobulin. The process includes the removal of thrombus-producing materials and impurities using anion and cation exchange resin purification techniques. This method improves the efficiency of impurity removal while maintaining a stable polymer content, resulting in high-quality hepatitis B immunoglobulin.
Career Highlights
Jong Kyung Kim is associated with Green Cross Holdings Corporation, where he applies his expertise in immunology and patent development. His work has contributed to advancements in the production of therapeutic proteins, which are crucial for treating hepatitis B.
Collaborations
He has collaborated with notable colleagues, including Yong Uk Shin and Dong Il Park, who share a commitment to advancing medical science and improving patient outcomes through innovative research.
Conclusion
Jong Kyung Kim's contributions to the field of immunology, particularly through his patented methods for preparing hepatitis B immunoglobulin, highlight his role as an influential inventor. His work not only enhances the quality of immunoglobulin preparations but also underscores the importance of innovation in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile